Gugulethu Tshabalala to Anti-HIV Agents
This is a "connection" page, showing publications Gugulethu Tshabalala has written about Anti-HIV Agents.
Connection Strength
0,639
-
Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries. PLoS One. 2023; 18(10):e0285132.
Score: 0,120
-
A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe. J Int AIDS Soc. 2022 08; 25(8):e25975.
Score: 0,110
-
Understanding Repeat Positive HIV Testing in South Africa Under Changing Treatment Guidelines. AIDS Behav. 2022 May; 26(5):1366-1376.
Score: 0,104
-
Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa. Arch Sex Behav. 2021 05; 50(4):1729-1742.
Score: 0,101
-
Understanding the role of resilience resources, antiretroviral therapy initiation, and HIV-1 RNA suppression among people living with HIV in South Africa: a prospective cohort study. AIDS. 2019 06 01; 33 Suppl 1:S71-S79.
Score: 0,088
-
Internalized HIV stigma, ART initiation and HIV-1 RNA suppression in South Africa: exploring avoidant coping as a longitudinal mediator. J Int AIDS Soc. 2018 10; 21(10):e25198.
Score: 0,084
-
Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075. AIDS Behav. 2024 Jul; 28(7):2361-2377.
Score: 0,031